Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOLIFE SOLUTIONS INC Director's Dealing 2020

Oct 8, 2020

32106_dirs_2020-10-07_2ff28251-f01a-4578-8982-1a133b31ea2f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2020-10-05

Reporting Person: COHEN RAYMOND W (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-10-05 Common Stock A 5000 Acquired 28388 Direct

Footnotes

F1: The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan and vests on the twelve-month anniversary of the grant date.